Similar articles

• [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].

  Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T. Horiguchi S, et al. Arerugi. 2008 May;57(5):558-61. Arerugi. 2008. PMID: 18520178 Clinical Trial. Japanese.
• [One point message of PG-MARJ 2005 (Allergic Rhinitis) treatment of Japanese cedar pollinosis].

  Konno A. Konno A. Arerugi. 2008 Jul;57(7):817-23. Arerugi. 2008. PMID: 18688181 Review. Japanese. No abstract available.
• [Prophylactic and therapeutic vaccines for Japanese cedar pollinosis].

  Ishii Y. Ishii Y. Nihon Yakurigaku Zasshi. 2010 Jun;135(6):250-3. doi: 10.1254/fpj.135.250. Nihon Yakurigaku Zasshi. 2010. PMID: 20543516 Japanese. No abstract available.
• Long-term immunological effects of Japanese cedar pollen-based subcutaneous immunotherapy.

  Inuo C, Ando H, Tanaka K, Nakajima Y, Tsuge I, Urisu A, Kondo Y. Inuo C, et al. Allergol Int. 2018 Jul;67(3):408-410. doi: 10.1016/j.alit.2017.11.002. Epub 2017 Dec 1. Allergol Int. 2018. PMID: 29198713 No abstract available.
• [Significance and methods of allergen immunotherapy for pollinosis].

  Ohkubo K. Ohkubo K. Arerugi. 2008 Feb;57(2):73-8. Arerugi. 2008. PMID: 18349580 Review. Japanese. No abstract available.